Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

An overview of the biological and psychosocial context surrounding neurocognition in HIV.

Vance DE, Randazza J, Fogger S, Slater LZ, Humphrey SC, Keltner NL.

J Am Psychiatr Nurses Assoc. 2014 Mar-Apr;20(2):117-24. doi: 10.1177/1078390314527549. Review.

PMID:
24717830
2.

The Role of Employment on Neurocognitive Reserve in Adults With HIV: A Review of the Literature.

Vance DE, Cody SL, Yoo-Jeong M, Jones GL, Nicholson WC.

J Assoc Nurses AIDS Care. 2015 Jul-Aug;26(4):316-29. doi: 10.1016/j.jana.2015.04.003. Epub 2015 Apr 11. Review.

3.

Depression and neurocognitive performance in Portuguese patients infected with HIV.

Bragan├ža M, Palha A.

AIDS Behav. 2011 Nov;15(8):1879-87. doi: 10.1007/s10461-011-9973-3.

PMID:
21598031
4.

Interactive effects of neurocognitive impairment and substance use on antiretroviral non-adherence in HIV disease.

Thaler NS, Sayegh P, Kim MS, Castellon SA, Hinkin CH.

Arch Clin Neuropsychol. 2015 Mar;30(2):114-21. doi: 10.1093/arclin/acu092. Epub 2015 Jan 14.

5.

Aging, neurocognition, and medication adherence in HIV infection.

Ettenhofer ML, Hinkin CH, Castellon SA, Durvasula R, Ullman J, Lam M, Myers H, Wright MJ, Foley J.

Am J Geriatr Psychiatry. 2009 Apr;17(4):281-90. doi: 10.1097/JGP.0b013e31819431bd.

6.

Depressive symptoms and neurocognitive performance among HIV-infected women.

Fialho RM, Pereira M, Mendon├ža N, Ouakinin S.

Women Health. 2013;53(2):117-34. doi: 10.1080/03630242.2013.767301.

PMID:
23517511
7.

Neurocognitive impairment influences quality of life in HIV-infected patients receiving HAART.

Tozzi V, Balestra P, Murri R, Galgani S, Bellagamba R, Narciso P, Antinori A, Giulianelli M, Tosi G, Fantoni M, Sampaolesi A, Noto P, Ippolito G, Wu AW.

Int J STD AIDS. 2004 Apr;15(4):254-9.

PMID:
15075020
8.

Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence.

Moore DJ, Blackstone K, Woods SP, Ellis RJ, Atkinson JH, Heaton RK, Grant I; Hnrc Group And The Tmarc Group..

AIDS Care. 2012;24(12):1504-13. doi: 10.1080/09540121.2012.672718. Epub 2012 Apr 24.

9.

Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression.

Cysique LA, Brew BJ.

J Neurovirol. 2011 Apr;17(2):176-83. doi: 10.1007/s13365-011-0021-x. Epub 2011 Mar 17.

PMID:
21416169
10.

Neurocognitive impairment and medication adherence in HIV patients with and without cocaine dependence.

Meade CS, Conn NA, Skalski LM, Safren SA.

J Behav Med. 2011 Apr;34(2):128-38. doi: 10.1007/s10865-010-9293-5. Epub 2010 Sep 21.

11.

Neurocognitive impairment and HIV risk factors: a reciprocal relationship.

Anand P, Springer SA, Copenhaver MM, Altice FL.

AIDS Behav. 2010 Dec;14(6):1213-26. doi: 10.1007/s10461-010-9684-1. Review.

12.

The cognitive consequences of stigma, social withdrawal, and depression in adults aging with HIV.

Vance DE.

J Psychosoc Nurs Ment Health Serv. 2013 May;51(5):18-20. doi: 10.3928/02793695-20130315-01. Epub 2013 Mar 22.

PMID:
23521077
13.

Longitudinal change in cognitive function and medication adherence in HIV-infected adults.

Becker BW, Thames AD, Woo E, Castellon SA, Hinkin CH.

AIDS Behav. 2011 Nov;15(8):1888-94. doi: 10.1007/s10461-011-9924-z.

14.

A pilot study of the neuropsychological benefits of computerized cognitive rehabilitation in Ugandan children with HIV.

Boivin MJ, Busman RA, Parikh SM, Bangirana P, Page CF, Opoka RO, Giordani B.

Neuropsychology. 2010 Sep;24(5):667-73. doi: 10.1037/a0019312.

PMID:
20804255
15.

Metabolic disorders and cardiovascular risk in HIV-infected patients treated with antiretroviral agents.

Fantoni M, Del Borgo C, Autore C, Barbaro G.

Ital Heart J. 2002 May;3(5):294-9. Review.

PMID:
12066561
16.

"It's a hidden issue": exploring the experiences of women with HIV-associated neurocognitive challenges using a disability framework.

Gallagher S, Biro S, Creamer E, Della Rossa E, Collins E, Rourke S, Nixon S.

Disabil Rehabil. 2013 Jan;35(1):36-46. doi: 10.3109/09638288.2012.687029. Epub 2012 May 24.

PMID:
22621682
17.

Characterization of HIV-Associated Neurocognitive Disorders among individuals starting antiretroviral therapy in South Africa.

Joska JA, Westgarth-Taylor J, Myer L, Hoare J, Thomas KG, Combrinck M, Paul RH, Stein DJ, Flisher AJ.

AIDS Behav. 2011 Aug;15(6):1197-203. doi: 10.1007/s10461-010-9744-6.

PMID:
20614176
18.

Neurocognitive aspects of medication adherence in HIV infection.

Selnes OA.

J Acquir Immune Defic Syndr. 2002 Dec 15;31 Suppl 3:S132-5. Review.

PMID:
12562036
19.

Fatigue in HIV/AIDS is associated with depression and subjective neurocognitive complaints but not neuropsychological functioning.

Millikin CP, Rourke SB, Halman MH, Power C.

J Clin Exp Neuropsychol. 2003 Apr;25(2):201-15.

PMID:
12754678
20.

Supplemental Content

Support Center